References
- ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Supplement 1):S62–S69.
- ADA. Standards of medical care in diabetes - 2014. Diabetes Care. 2014;37:S14– S80.
- IDF diabetes atlas: global estimates of the prevalence of diabetes for 2015 and 2040. Available from: http://www.diabetesatlas.org/
- Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.
- Riaz H, Godman B, Bashir S, et al. Evaluation of drug use indicators for non-communicable diseases in Pakistan. Acta Pol Pharm. 2016;73(3):787–794.
- ADA. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(Supplement 1):S11–S66.
- WHO. Adherence to long term therapies. Available from: http://www.who.int/chp/knowledge/publications/adherence_Section1.pdf
- Sabaté E Adherence to long-term therapies: evidence for action: World Health Organization. 2003. Available from: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf
- DiMatteo MR, Sherbourne CD, Hays RD, et al. Physicians’ characteristics influence patients’ adherence to medical treatment: results from the medical outcomes study. Health Psychol. 1993;12(2):93–102.
- Van Servellen G, Chang B, Garcia L, et al. Individual and system level factors associated with treatment non adherence in human immunodeficiency virus-infected men and women. AIDS Patient Care STDS. 2002;16(6):269–281.
- Barbui C, Conti V. Adherence to generic v. brand antidepressant treatment and the key role of health system factors. Epidemiol Psychiatr Sci. 2015;24(01):23–26.
- Roberts B, Stickley A, Balabanova D, et al. Irregular treatment of hypertension in the former Soviet Union. J Epidemiol Community Health. 2012;66(6):482–488.
- Shrank WH, Hoang T, Ettner SL, et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006;166(3):332–337.
- Simoens S, Sinnaeve PR. Patient co-payment and adherence to statins: a review and case studies. Cardiovasc Drugs Ther. 2014;28(1):99–109.
- Khan MA, Sultan SM, Nazli R, et al. Depression among patients with type-2 diabetes mellitus. J Coll Physicians Surg Pak. 2014;24(10):770–771.
- IDF. Prevalence estimates of diabetes mellitus (DM) - MENA 2010. Available from: http://www.idf.org/content/mena-data
- Jafar T, Levey A, White F, et al. Ethnic differences and determinants of diabetes and central obesity among South Asians of Pakistan. Diabetic Med. 2004;21(7):716–723.
- Shera A, Jawad F, Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract. 2007;76(2):219–222.
- Abbas A, Kachela B, Arif JM, et al. Assessment of medication adherence and knowledge regarding the disease among ambulatory patients with diabetes mellitus in Karachi, Pakistan. J Young Pharm. 2015;7(4):329–340.
- Imtiaz S, Ullah H, Rasool MF, et al. Assessment of compliance of diabetic patients at Nishtar Hospital Multan, Pakistan. Gomal J Med Sci. 2014;12(2):84–88.
- Nazir SUR, Hassali MA, Saleem F, et al. Disease related knowledge, medication adherence and glycaemic control among patients with type 2 diabetes mellitus in Pakistan. Primary Care Diabetes. 2016;10(2):136–141.
- Shams N, Amjad S, Ahmed W, et al. Drug non-adherence in type 2 diabetes mellitus; predictors and associations. J Ayub Med Coll Abbottabad. 2016;28(2):302–307.
- Daniel WW. Biostatistics: basic concepts and methodology for the health sciences. New York: John Wiley & Sons; 2010. Available from https://www.amazon.co.uk/Biostatistics-Concepts-Methodology-Probability-Statistics/dp/0470413336
- Gorstein J, Sullivan KM, Parvanta I et al. Indicators and methods for cross-sectional surveys of vitamin and mineral status of populations. Available from: http://www.who.int/vmnis/toolkit/mcn-micronutrient-surveys.pdf
- Saleem F, Hassali M, Shafie AA, et al. Association between knowledge and drug adherence in patients with hypertension in Quetta, Pakistan. Trop J Pharm Res. 2011;10(2):125–132.
- Chong E, Wang H, King‐Shier K, et al. Prescribing patterns and adherence to medication among South‐Asian, Chinese and white people with Type 2 Diabetes Mellitus: a population‐based cohort study. Diabetic Med. 2014;31(12):1586–1593.
- Divya S, Nadig P. Factors contributing to non-adherence to medication among type 2 diabetes mellitus in patients attending tertiary care hospital in South India. Asian J Pharm Clin Res. 2015;8(2):274–276.
- Pirdehghan A, Poortalebi N. Predictors of adherence to type2 diabetes medication. J Res Health Sci. 2016;1(16):72–75.
- Osterberg L, Blaschke T. Adherence to medication. Nejm. 2005;353(5):487–497.
- Saleem F, Hassali MA, Shafie AA, et al. Does treatment adherence coorelates with health related quality of life? Findings from a cross sectional study. BMC Public Health. 2012;12:318.
- Saleem F, Hassali M, Shafie A, et al. Translation and validation study of 14-item Michigan Diabetes Knowledge Test (MDKT): the Urdu version. Value in Health. 2011;14(7):A481.
- Al-Qazaz HK, Hassali MA, Shafie AA, et al. The 14-item Michigan Diabetes Knowledge Test: translation and validation study of the Malaysian version. Pract Diab Int. 27(6):238–41a.
- Abebaw M, Messele A, Hailu M, et al. Adherence and associated factors towards antidiabetic medication among type 2 diabetic patients on follow-up at University of Gondar Hospital, Northwest Ethiopia. Adv Nurs. 2016;1–7.
- Sweileh WM, Sa’ed HZ, Nab’a RJA, et al. Influence of patients’ disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014;14(14):94.
- Peters DH, Rao KS, Fryatt R. Lumping and splitting: the health policy agenda in India. Health Policy Plan. 2003;18(3):249–260.
- WHO Organization, 2016. Available from: http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1
- Riaz H, Finlayson AE, Bashir S, et al. Prevalence of vitamin D deficiency in Pakistan and implications for the future. Expert Rev Clin Pharmacol. 2016;9(2):329–338.
- Editorial. Kenya first country to launch ‘Novartis Access’, expanding affordable treatment options against chronic diseases. Available from: https://www.novartis.com/news/media-releases/kenya-first-country-launch-novartis-access-expanding-affordable-treatment
- Novartis access. Available from: https://www.novartis.com/about-us/corporate-responsibility/expanding-access-healthcare/novartis-access
- Khan B, Godman B, Babar A, et al. Assessment of active pharmaceutical ingredients in the registration procedures in pakistan: implications for the future. Gabi J. 2016;5(4):154–163.
- Azhar S, Hassali M, Ibrahim M. Doctors’ perception and expectations of the role of the pharmacist in Punjab, Pakistan. Trop J Pharm Res. 2010;9(3):205–222.
- Azhar S, Hassali MA, Ibrahim MM. Perceptions of hospital pharmacist’s role in Pakistan’s healthcare system: a cross-sectional survey. Trop J Pharm Res. 2011;10(1):11–17.
- Community Pharmacy Scotland. (2016). What is the new medicines intervention support tool (NMIST)? Available from: http://www.communitypharmacyscotland.org.uk/nhs-care-services/services/chronic-medication-service/new-medicine-intervention-support-tool/about-the-new-medicine-intervention-support-tool/
- Godman B, Acurcio FA, Guerra Jnr AA, et al. Initiatives among authorities to improve the quality and efficiency of prescribing and the implications. J Pharm Care Health Syst. 2014;8(1):7–24.
- Kooij MJ, Heerdink ER, Van Dijk L, et al. Effects of telephone counseling intervention by pharmacists (TelCIP) on medication adherence; results of a cluster randomized trial. Front Pharmacol. 2016;7:269.
- The Scottish Government. Prescription for excellence: a vision and action plan for the right pharmaceutical care through integrated partnerships and innovation. 2013. Available from: http://www.gov.scot/Publications/2013/09/3025
- Meece J. Improving medication adherence among patients with type 2 diabetes. J Pharm Pract. 2014;27(2):187–194.
- Antoine S-L, Pieper D, Mathes T, et al. Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials. BMC Endocr Disord. 2014;14(1):53.
- Riaz H, Godman B, Hussain S, et al. Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future. J Pharm Health Serv Res. 2015;6:111–121.
- Holloway K, Green T. Drug and Therapeutics Committees: a practical guide. 2003. Available from: http://apps.who.int/medicinedocs/pdf/s4882e/s4882e.pdf